How Noom Is Reducing GLP-1 Side Effects (#454)
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
How Noom Is Reducing GLP-1 Side Effects (#454)
-
ナレーター：
-
著者：
このコンテンツについて
Noom CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler highlight early results from the company’s microdosing program, the changes that happen as GLP-1's continue to dominate much of the public conversation about weight loss, and what physicians think about it all.
All that, plus the Flava of the Week about leadership changes at CVS Health. Who is in, who is out, and what do the changes signal about the retail giant’s direction in the near term?
SPOTLIGHT: FRIDAYS
Lose weight with GLP-1 + GIP treatment, lifestyle coaching, and full support, for one transparent price. Everything you need to achieve lasting results: medical guidance, personalized coaching, insurance assistance, and a supportive community. No surprises. No fine print.
Get your custom plan today: www.joinfridays.com/?utm_source=referral&utm_medium=podcast&utm_campaign=healthcare_rap
JOIN THE COMMUNITY
This show is produced by the Healthcare Rap Community. Come learn how to bridge the gap between sick care and well care as we highlight the consumer POV in healthcare! (#454)
Join today: healthcarerapcommunity.com
See omnystudio.com/listener for privacy information.